The financial industry favors arbitration for the certainty it affords as well as the defined obligations, cost savings and streamlined process it provides. But these benefits can be forfeited due to lack of preparation. Join Fox partners Josh Horn and Oksana Wright on Thursday, November 5 at 3 pm ET for a step-by-step training on preparing for a FINRA arbitration hearing.

Fox IP attorney Gerard Norton told Law360 that a recent Federal Circuit decision has generic drug makers worried because it undercuts specific protections in the Hatch-Waxman Act. "They're all bioequivalents, that's the whole point," Norton said. "You don't have to do clinical trials so long as you show it's the same structure and compound, and you provide the data and the evidence to FDA that it is, then you're going to get bioequivalence."

The COVID-19 pandemic directly impacts businesses in myriad ways. Our Coronavirus Response Resource Center spans dozens of legal practice areas and provides links to free webinars, alerts, articles and charts with practical guidance for leaders of companies of all sizes. The page is updated daily and includes sections on the CARES Act and FFCRA, as well as state-specific alerts.